Haemolytic-uraemic syndrome during severe lupus nephritis: Efficacy of plasma exchange

Internal Medicine Journal

Volumn 42, Issue 1, 2012, Pages 95-98

  Samson, M ^a,b   Audia, S ^a,b   Leguy, V ^a   Berthier, S ^a   Janikashvili, N ^b   Martin, L ^a,b   Bonnotte, B ^a,b   Lorcerie, B ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Haemolyticuraemic syndrome; Lupus nephritis; Plasma exchange; Systemic lupus erythematosus; Thrombotic microangiopathy

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTHRALGIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DISEASE ASSOCIATION; EDEMA; FEMALE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ACUTE KIDNEY INJURY; ADULT; BIOPSY; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; ERYTHROCYTES, ABNORMAL; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS NEPHRITIS; METHYLPREDNISOLONE; MODELS, IMMUNOLOGICAL; MYCOPHENOLIC ACID; PLASMA EXCHANGE; PREDNISONE;

EID: 84856252985     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02591.x     Document Type: Article

References (11)

1. Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA etal. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine 2004; 83: 233-44.
2. Hamasaki K, Mimura T, Kanda H, Kubo K, Setoguchi K, Satoh T etal. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 2003; 22: 355-8.
3. Amoura Z, Costedoat-Chalumeau N, Veyradier A, Wolf M, Ghillani-Dalbin P, Cacoub P etal. Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome. Arthritis Rheum 2004; 50: 3260-4.
4. Copelovitch L, Kaplan BS. The thrombotic microangiopathies. Pediatr Nephrol 2008; 23: 1761-7.
5. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98: 1765-72.
6. Tostivint I, Mougenot B, Flahault A, Vigneau C, Costa MA, Haymann JP etal. Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transplant 2002; 17: 1228-34.
7. Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P etal. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006; 108: 1267-79.
8. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-35.
9. Hunt BJ, Tueger S, Pattison J, Cavenagh J, D'Cruz DP. Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus 2007; 16: 358-62.
10. Zipfel PF. Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage? Trends Immunol 2001; 22: 345-8.
11. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H etal. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555-63.